SEC Form 4 · accession 0000939767-18-000184
EXELIXIS, INC. · EXEL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vincent T Marchesi
Director
Period of report
Aug 15, 2018
Accepted (ET)
Aug 17, 2018 · 7:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000939767
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 15, 2018 | M | 40,000 | $3.38 | A | 173,850 | D | |
| Common StockF2 | Aug 15, 2018 | S | 40,000 | $19.50 | D | 133,850 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F3 | $3.38 | Aug 15, 2018 | M | 40,000 | D | May 29, 2014 | May 28, 2021 | Common Stock | 40,000 | 0 | D |
Explanation of responses
- F1Includes 7,937 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
- F2Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $19.50 to $19.52. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
- F3The option, representing the right to purchase a total of 40,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 29, 2014.